BIOFARMA
Instituto Cajal
Madrid, EspañaPublicacións en colaboración con investigadores/as de Instituto Cajal (6)
2018
-
Genetic enhancement of Ras-ERK pathway does not aggravate L-DOPA-induced dyskinesia in mice but prevents the decrease induced by lovastatin
Scientific Reports, Vol. 8, Núm. 1
1996
-
Synthesis and affinities for dopamine (D2) and 5-hydroxytryptamine (5-HT2A) receptors of 1-(benzoylpropyl)-4-(1-oxocycloalkyl-2-ethyl)-piperazines as cyclic butyrophenone derivatives
Chemical and Pharmaceutical Bulletin, Vol. 44, Núm. 3, pp. 534-541
1995
-
Butyrophenone analogues: Synthesis of 2-methyl-3-ethyl-5-aminoethyl-4,5,6,7-tetrahydroindol-4-ones, and their affinities for d 1 , d 2 and 5-ht 2a receptors
Bioorganic and Medicinal Chemistry Letters, Vol. 5, Núm. 6, pp. 579-584
1994
-
Pyridazine derivatives XII. Synthesis and antipsychotic-antidepressant activity of some butyrophenone derivatives of 6-phenylpyridazine
European Journal of Medicinal Chemistry, Vol. 29, Núm. 11, pp. 831-839
-
Synthesis and Atypical Antipsychotic Profile of Some 2-(2-Piperidinoethyl)benzocycloalkanones as Analogs of Butyrophenone
Journal of Medicinal Chemistry, Vol. 37, Núm. 16, pp. 2564-2573
1991
-
5-HT2 antagonist activity of 3-aminomethyltetralones
Bioorganic and Medicinal Chemistry Letters, Vol. 1, Núm. 12, pp. 717-720